Scrutinise runs entirely on public information. Every analysis is built from published clinical trials and the public scientific literature. We do not capture, access, store, or use any commercially sensitive or confidential data from our customers to produce it.
Scrutinise (scrutinise.ai) keeps data collection to the minimum needed to run an early-access beta. This policy explains what we collect, why, and the choices you have.
When you join the beta list, we collect the email address you enter. We do not ask for your name, company, or any other detail at signup, and we do not collect it automatically.
We do not run advertising or analytics trackers on this site, and we do not set non-essential cookies.
We use your email address only to send you the evidence library you requested and occasional updates about the Scrutinise beta. The lawful basis is your consent, given when you submit the form.
We send email through Resend, our email delivery provider, which stores your address on our behalf to deliver these messages. Resend operates in the United States, so your email address is transferred and stored there. We do not sell or share your data with anyone else.
We keep your email address for as long as the beta runs or until you unsubscribe, whichever comes first. After that we delete it.
You can unsubscribe at any time using the link in any email we send. You can also ask us to show, correct, or delete the data we hold about you by emailing privacy@scrutinise.ai. If you are in the EU, UK, or another region with data-protection rights, those rights apply and you may also complain to your local regulator.
If this policy changes, we will update the date above. Material changes affecting how we use your email will be notified by email.
Questions about privacy: privacy@scrutinise.ai